Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2

Endocrinology

Volumn 142, Issue 5, 2001, Pages 1889-1898

  Hoeflich, Andreas ^a   Nedbal, Sabine ^a   Blum, Werner F ^b   Erhard, Michael ^a   Lahm, Harald ^a   Brem, Gottfried ^d   Kolb, Helmut J ^c   Wanke, Rüdiger ^a   Wolf, Eckhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c Institute of Clinical Chemistry   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 2;

ANIMAL TISSUE; ARTICLE; BODY GROWTH; CONTROLLED STUDY; GROWTH REGULATION; MOUSE; NONHUMAN; ORGAN GROWTH; ORGAN WEIGHT; POSTNATAL GROWTH; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0035049816     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.5.8149     Document Type: Article

References (62)

1. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
2. 3IGF-1 differently affect development and messenger RNA abundance for IGF-binding proteins and type I IGF receptors in in vitro produced bovine embryos
3. Human insulin-like growth factor-I produced in the mammary glands of transgenic rabbits: Yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins
4. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: Endocrine changes and effects on body and organ growth
5. Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system
6. Effects of IGFBP-2 overexpression in vitro and in vivo
7. Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae
8. Insulin-like growth factor binding protein-2 potently inhibits cell proliferation in human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines
9. Overexpression of insulin-like growth factor-binding protein-2 in C6 glioma cells results in conditional alteration of cellular growth
10. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: Modulation by transforming growth factor-beta and retinoic acid
11. IGFBP-2 expression in a human cell line is associated with Increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity
12. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells
13. Genetic ablation of IGFBP-2 suggests functional redundancy in the IGFBP family
14. Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene
15. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain
16. Multiple consequences of human growth hormone expression in transgenic mice
17. Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. I. Body weight gain and external body dimensions
18. Expression of metallothionein-human growth hormone fusion genes in transgenic mice results in disproportionate skeletal gigantism
19. Relative growth of the skull and postcranium in giant transgenic mice
20. Linear bone growth of oMtla-oGH transgenic male mice
21. Growth allometry of the organs in giant transgenic mice
22. Growth allometry of transgenic mice expressing the mouse metallothionein-I/bovine growth hormone gene
23. Actions and interactions of growth hormone and insulin-like growth factor-II: Body and organ growth of transgenic mice
24. Overgrowth of the skin in growth hormone transgenic mice depends on the presence of male gonads
25. Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family. An overview
26. The GH-transgenic mouse as an experimental model for growth research: Clinical and pathological studies
27. Physiology and pathology of growth - Studies in GH transgenic mice
28. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models
29. Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice
30. Effects of growth hormone overproduction on grip strength of transgenic mice
31. Clinical studies of IGFBP-2 by radioimmunoassay
32. Radioimmunoassays for insulin-like growth factors and their binding proteins
33. Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth Factors
34. Identification of antigenic differences of recombinant and pituitary bovine growth hormone using monoclonal antibodies
35. Interactions of insulin-like growth factor-II (IGF-II) and growth hormone (GH) in vivo: Circulating levels of IGF-I and IGF-bindIng proteins in transgenic mice
36. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice
37. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone
38. Growth enhancement of transgenic mice expressing human insulin-like growth factor I
39. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat
40. Recombinant human insulin-ike growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats
41. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I
42. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
43. Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I
44. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (Igf1r)
45. IGF-I is required for normal embryonic growth in mice
46. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice
47. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice
48. In vivo effects of insulin-like growth factor-I on the development of sensory pathways: Analysis of the primary somatic sensory cortex (S1) of transgenic mice
49. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice
50. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
51. Brain growth retardation due to the expression of human insulin like growth factor binding protein-1 in transgenic mice: An in vivo model for the analysis of IGF function in the brain
52. Insulin-like growth factor-I influences the initiation of myelination: Studies of the anterior commissure of transgenic mice
53. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice
54. Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1
55. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins
56. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
57. Normal growth and development in the absence of hepatic insulin-like growth factor I
58. The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver
59. New murine model for hepatocellular carcinoma: Transgenic mice expressing metallothionein-ovine growth hormone fusion genes
60. Growth hormone overproduction in transgenic mice: Phenotypic alterations and deduced animal models
61. Human insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: Characterization and insights into the regulation of IGFBP-1 expression
62. Reduced fecundity in insulin-like growth factor-binding protein-1 transgenic mice